Healthcare - Biotechnology - NASDAQ - US
$ 0.569
2.89 %
$ 65.7 M
Market Cap
-0.65
P/E
INCOME STATEMENT
0
REVENUE
-181 M
OPERATING INCOME
-190 M
NET INCOME
EFFICIENCY
Earnings Waterfall
AlloVir, Inc.
| Revenue | 0 |
| Cost Of Revenue | 398 K |
| Gross Profit | -398 K |
| Operating Expenses | 181 M |
| Operating Income | -181 M |
| Other Expenses | 9.09 M |
| Net Income | -190 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0.2 | 1.1 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.4 | 2.6 | 1.1 | 73 K | 0 | 0 |
| Gross Profit | (0.4) | (2.6) | (1.1) | 73 K | 0.2 | 1.1 |
| OPERATING INCOME | ||||||
| Operating Expenses | 180.9 | 171.2 | 169.8 | 71.3 | 26.9 | 4.7 |
| Selling, General and Administrative Expenses | 48.3 | 52.3 | 49.1 | 21.6 | 10.6 | 3.0 |
| Research and Development Expenses | 133.1 | 118.9 | 120.7 | 49.7 | 16.2 | 1.7 |
| Operating Income | (181.3) | (171.2) | (169.8) | (71.3) | (26.7) | (3.6) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | (3.0) | 0 | 0 | 0 | 0 |
| Total Other Income | (9.2) | 2.2 | (1.1) | 1.5 | 2.9 | 1.2 |
| Pre-Tax Income | (190.5) | (169.0) | (171.0) | (69.8) | (23.8) | (2.4) |
| NET INCOME | ||||||
| Tax Provision | (0.1) | (0.3) | 1.0 | (1.4) | (2.1) | 1.2 |
| Net Income | (190.4) | (168.7) | (172.0) | (68.4) | (21.8) | (2.4) |
| EPS | 1.83 | 2.2 | 2.74 | 2.54 | 0.33 | 0.0655 |